<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02350881</url>
  </required_header>
  <id_info>
    <org_study_id>1202-T-FGTI-M</org_study_id>
    <nct_id>NCT02350881</nct_id>
  </id_info>
  <brief_title>Mid-term Outcomes of First MTP Arthroplasty With Primus™ FGT Implant.</brief_title>
  <official_title>A Post-Market Observational Study to Evaluate Safety and Performance of Primus™ FGT Implant at a Minimum of 5 Years Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tornier, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tornier, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Foot silicone implants suffer from bad reputation on the market, due to poor results obtained
      with the first generations of implants. Allergies to silicone, infections due to silicone and
      implants breakage used to be common with previous generations of silicone implants.
      Publications relative to those implants showed that the survival rates after 5 years of
      follow-up were unsatisfactory.

      Since 1998, Tornier has been selling a new generation of silicone implants made of Ultrasil™.
      The use of this new material in its manufacturing process together with its innovative
      geometry, make the Primus™ FGT a much more resistant, anatomic and long lasting implant.

      The main objective of this study is to evaluate the clinical outcomes of the implantation of
      Primus™ FGT implant in great toe arthroplasty. The study will capture long term outcomes in
      terms of functional metrics from documented clinical data. Other objectives are to evaluate
      the outcomes in terms of radiological evaluation and of safety during all the follow-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational post-marketing surveillance study, performed by 1 (one) investigator
      in 1 (one) Italian site.

        -  Preoperative and peroperative data were collected retrospectively.

        -  Postoperative data (minimum 5 years follow-up or until implant revision) were collected
           prospectively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>AOFAS Hallux-MTP-IP Score - Overall</measure>
    <time_frame>mean 6.9 years follow-up (range 5.2 - 9.5)</time_frame>
    <description>AOFAS (American Orthopedic Foot and Ankle Society) Hallux-MTP-IP (Hallux-Meta-Tarso-Phalangeal-Inter-Phalangeal) score is composed of 3 sub-scores : (i) Pain score is ranging from 0 to 40 points ; Function score is ranging from 0 to 45 points ; Alignment is ranging from 0 to 15 points. The AOFAS total score is then ranging from 0 to 100 points. A result over 80 points is considered &quot;good&quot;, below 20 points as &quot;bad&quot;.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AOFAS Hallux-MTP-IP - PAIN Score</measure>
    <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
    <description>Pain is a sub-score of the AOFAS Hallux-MTP-IP score and is measured on a scale of 40 points - the higher value represents a minimal pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain at Passive Motion of MTP1</measure>
    <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
    <description>Number of patients reporting pain at passive motion of MTP1 at preoperative and postoperative visits.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain at Pressure of MTP1</measure>
    <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
    <description>Number of patients reporting pain at pressure of MTP1 at preoperative and postoperative visits.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Walking Perimeter</measure>
    <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
    <description>Subjective evaluation by the patients of their walking perimeter, postoperatively versus preoperatively. Patient had to choose among 3 variables : &quot;improved&quot;, &quot;same&quot;, &quot;worsened&quot;.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain During Walking</measure>
    <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
    <description>Subjective evaluation by patients about pain during walking, postoperatively versus preoperatively. Patients had to choose among 4 variables : &quot;disappeared&quot;, &quot;less&quot;, same&quot;, &quot;greater&quot;.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain at Rest</measure>
    <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
    <description>Subjective evaluation of patients about ther pain at rest, postoperatively versus preoperatively. Patients had to choose among 4 variables : &quot;disappeared&quot;, &quot;less&quot;, &quot;same, &quot;greater&quot;.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Osteolysis</measure>
    <time_frame>mean 6.9 years (range, 5.5 - 9.5)</time_frame>
    <description>Osteolysis evaluation was described as : absent or present. Radiological evaluations were done from available frontal and lateral view X-rays.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone Resorption</measure>
    <time_frame>mean 6.9 years (range, 5.5 - 9.5)</time_frame>
    <description>Bone resorption evaluation was described as : absent or present. Radiological evaluations were performed from available frontal and lateral view X-rays.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival of the Implant.</measure>
    <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
    <description>The survival of the implant is evaluated according to the number of implant revisions or of reoperations, whatever the reason.</description>
  </secondary_outcome>
  <enrollment type="Actual">70</enrollment>
  <condition>Hallux Limitus of Left Great Toe</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Arthritis of 1st Metatarsophalangeal Joint</condition>
  <condition>Osteoarthritis</condition>
  <condition>Bunion</condition>
  <condition>Hallux Limitus of Right Great Toe</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Primus FGTI (Flexible Great toe Implant)</intervention_name>
    <description>Great toe arthroplasty consists of replacing the first Meta-Tarso-Phalangeal (MTP1) joint by a two hinged prosthesis made of silicone : the Primus FGT implant (FGTI). The Primus is designed with an axially offset hinge to align with the anatomy of the MTP joint. This results in less implant stresses and improved toe function.</description>
    <other_name>First metatarsophalangeal arthroplasty</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This study has included all patients who had had a Primus™ FGT implantation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient has had a Primus™ FGT implantation for one of the following indications:
             hallux limitus, hallux rigidus, hallux abducto valgus associated with severe
             arthritis, unstable or painful joint from previous surgery on the great toe,

          -  patient having all necessary clinical and radiographical data available.,

          -  patient has been informed about this scientific study and has provided their Consent
             to participate.

        Exclusion Criteria:

          -  patient does not have clinical and radiographic follow-up data available.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefano FIESCHI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Casa di Cura Villa Berica - Vicenza - Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Casa Di Cura Villa Berica</name>
      <address>
        <city>Vicenza</city>
        <zip>36100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2015</study_first_submitted>
  <study_first_submitted_qc>January 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2015</study_first_posted>
  <results_first_submitted>May 2, 2016</results_first_submitted>
  <results_first_submitted_qc>September 12, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 31, 2016</results_first_posted>
  <last_update_submitted>September 12, 2016</last_update_submitted>
  <last_update_submitted_qc>September 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Hallux Limitus</mesh_term>
    <mesh_term>Hallux Rigidus</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment period : from September 2013 to April 2014</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Overall Cohort</title>
          <description>one consecutive series of patients were included</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="64">64 patients were included (6 bilateral)</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="64">64 patients were completed (6 bilateral)</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>64 patients who received 70 implants (6 bilateral)</population>
      <group_list>
        <group group_id="B1">
          <title>Overall Cohort</title>
          <description>one consecutive series of patients were included</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="64"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.8" lower_limit="45" upper_limit="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>AOFAS Hallux-MTP-IP Score - Overall</title>
        <description>AOFAS (American Orthopedic Foot and Ankle Society) Hallux-MTP-IP (Hallux-Meta-Tarso-Phalangeal-Inter-Phalangeal) score is composed of 3 sub-scores : (i) Pain score is ranging from 0 to 40 points ; Function score is ranging from 0 to 45 points ; Alignment is ranging from 0 to 15 points. The AOFAS total score is then ranging from 0 to 100 points. A result over 80 points is considered &quot;good&quot;, below 20 points as &quot;bad&quot;.</description>
        <time_frame>mean 6.9 years follow-up (range 5.2 - 9.5)</time_frame>
        <population>number of implants analyzed (70 implants in 64 patients)</population>
        <group_list>
          <group group_id="O1">
            <title>Overall Cohort</title>
            <description>one consecutive series of patients were included</description>
          </group>
        </group_list>
        <measure>
          <title>AOFAS Hallux-MTP-IP Score - Overall</title>
          <description>AOFAS (American Orthopedic Foot and Ankle Society) Hallux-MTP-IP (Hallux-Meta-Tarso-Phalangeal-Inter-Phalangeal) score is composed of 3 sub-scores : (i) Pain score is ranging from 0 to 40 points ; Function score is ranging from 0 to 45 points ; Alignment is ranging from 0 to 15 points. The AOFAS total score is then ranging from 0 to 100 points. A result over 80 points is considered &quot;good&quot;, below 20 points as &quot;bad&quot;.</description>
          <population>number of implants analyzed (70 implants in 64 patients)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.9" spread="9.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>AOFAS Hallux-MTP-IP - PAIN Score</title>
        <description>Pain is a sub-score of the AOFAS Hallux-MTP-IP score and is measured on a scale of 40 points - the higher value represents a minimal pain.</description>
        <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
        <population>Overall cohort</population>
        <group_list>
          <group group_id="O1">
            <title>Overall Cohort</title>
            <description>one consecutive series of patients were included</description>
          </group>
        </group_list>
        <measure>
          <title>AOFAS Hallux-MTP-IP - PAIN Score</title>
          <description>Pain is a sub-score of the AOFAS Hallux-MTP-IP score and is measured on a scale of 40 points - the higher value represents a minimal pain.</description>
          <population>Overall cohort</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.4" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain at Passive Motion of MTP1</title>
        <description>Number of patients reporting pain at passive motion of MTP1 at preoperative and postoperative visits.</description>
        <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
        <population>Overall cohort</population>
        <group_list>
          <group group_id="O1">
            <title>Absent</title>
            <description>Number of patients reporting no pain</description>
          </group>
          <group group_id="O2">
            <title>Moderate</title>
            <description>Number of patients reporting a moderate pain</description>
          </group>
          <group group_id="O3">
            <title>Severe</title>
            <description>Number of patients reporting a severe pain</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at Passive Motion of MTP1</title>
          <description>Number of patients reporting pain at passive motion of MTP1 at preoperative and postoperative visits.</description>
          <population>Overall cohort</population>
          <units>Number of Implants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="64"/>
                <count group_id="O3" value="64"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Preoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Osteolysis</title>
        <description>Osteolysis evaluation was described as : absent or present. Radiological evaluations were done from available frontal and lateral view X-rays.</description>
        <time_frame>mean 6.9 years (range, 5.5 - 9.5)</time_frame>
        <population>Overall cohort</population>
        <group_list>
          <group group_id="O1">
            <title>Absence</title>
            <description>Number of feet where no osteolysis was observed</description>
          </group>
          <group group_id="O2">
            <title>Presence</title>
            <description>Number of feet where osteolysis was observed</description>
          </group>
        </group_list>
        <measure>
          <title>Osteolysis</title>
          <description>Osteolysis evaluation was described as : absent or present. Radiological evaluations were done from available frontal and lateral view X-rays.</description>
          <population>Overall cohort</population>
          <units>percentage of implants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.4"/>
                    <measurement group_id="O2" value="18.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bone Resorption</title>
        <description>Bone resorption evaluation was described as : absent or present. Radiological evaluations were performed from available frontal and lateral view X-rays.</description>
        <time_frame>mean 6.9 years (range, 5.5 - 9.5)</time_frame>
        <population>Overall cohort</population>
        <group_list>
          <group group_id="O1">
            <title>Absence</title>
            <description>Number of feet where no bone resorption was observed</description>
          </group>
          <group group_id="O2">
            <title>Presence</title>
            <description>Number of feet where bone resorption was observed</description>
          </group>
        </group_list>
        <measure>
          <title>Bone Resorption</title>
          <description>Bone resorption evaluation was described as : absent or present. Radiological evaluations were performed from available frontal and lateral view X-rays.</description>
          <population>Overall cohort</population>
          <units>percentage of implants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.3"/>
                    <measurement group_id="O2" value="35.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain at Pressure of MTP1</title>
        <description>Number of patients reporting pain at pressure of MTP1 at preoperative and postoperative visits.</description>
        <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
        <population>Overall cohort</population>
        <group_list>
          <group group_id="O1">
            <title>Absent</title>
            <description>Number of patients reporting no pain</description>
          </group>
          <group group_id="O2">
            <title>Moderate</title>
            <description>umber of patients reporting a moderate pain</description>
          </group>
          <group group_id="O3">
            <title>Severe</title>
            <description>Number of patients reporting a severe pain</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at Pressure of MTP1</title>
          <description>Number of patients reporting pain at pressure of MTP1 at preoperative and postoperative visits.</description>
          <population>Overall cohort</population>
          <units>Number of Implants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="64"/>
                <count group_id="O3" value="64"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Preperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Walking Perimeter</title>
        <description>Subjective evaluation by the patients of their walking perimeter, postoperatively versus preoperatively. Patient had to choose among 3 variables : &quot;improved&quot;, &quot;same&quot;, &quot;worsened&quot;.</description>
        <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
        <population>Overall cohort</population>
        <group_list>
          <group group_id="O1">
            <title>Improved</title>
            <description>Number of patients who declared an improvement in their walking perimeter</description>
          </group>
          <group group_id="O2">
            <title>Same</title>
            <description>Number of patients who declared no improvement in their walking perimeter</description>
          </group>
          <group group_id="O3">
            <title>Worsened</title>
            <description>Number of patients who declared a worsening of their walking perimeter</description>
          </group>
        </group_list>
        <measure>
          <title>Walking Perimeter</title>
          <description>Subjective evaluation by the patients of their walking perimeter, postoperatively versus preoperatively. Patient had to choose among 3 variables : &quot;improved&quot;, &quot;same&quot;, &quot;worsened&quot;.</description>
          <population>Overall cohort</population>
          <units>Number of Implants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="64"/>
                <count group_id="O3" value="64"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain During Walking</title>
        <description>Subjective evaluation by patients about pain during walking, postoperatively versus preoperatively. Patients had to choose among 4 variables : &quot;disappeared&quot;, &quot;less&quot;, same&quot;, &quot;greater&quot;.</description>
        <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
        <population>Overall cohort</population>
        <group_list>
          <group group_id="O1">
            <title>Disappeared</title>
            <description>Number of patients who declared an absence of pain during walking postoperatively</description>
          </group>
          <group group_id="O2">
            <title>Less</title>
            <description>Number of patients who declared a slight improvement of pain during walking postoperatively</description>
          </group>
          <group group_id="O3">
            <title>Same</title>
            <description>Number of patients who declared no improvement in pain during walking postoperatively</description>
          </group>
          <group group_id="O4">
            <title>Greater</title>
            <description>Number of patients who declared a worsening of pain during walking postoperatively</description>
          </group>
        </group_list>
        <measure>
          <title>Pain During Walking</title>
          <description>Subjective evaluation by patients about pain during walking, postoperatively versus preoperatively. Patients had to choose among 4 variables : &quot;disappeared&quot;, &quot;less&quot;, same&quot;, &quot;greater&quot;.</description>
          <population>Overall cohort</population>
          <units>Number of Implants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="64"/>
                <count group_id="O3" value="64"/>
                <count group_id="O4" value="64"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="70"/>
                <count group_id="O4" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain at Rest</title>
        <description>Subjective evaluation of patients about ther pain at rest, postoperatively versus preoperatively. Patients had to choose among 4 variables : &quot;disappeared&quot;, &quot;less&quot;, &quot;same, &quot;greater&quot;.</description>
        <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
        <population>Overall cohort</population>
        <group_list>
          <group group_id="O1">
            <title>Disappeared</title>
            <description>Number of patients who declared an absence of pain at rest postoperatively</description>
          </group>
          <group group_id="O2">
            <title>Less</title>
            <description>Number of patients who declared a slight improvement of pain at rest postoperatively</description>
          </group>
          <group group_id="O3">
            <title>Same</title>
            <description>Number of patients who declared no improvement in pain at rest postoperatively</description>
          </group>
          <group group_id="O4">
            <title>Greater</title>
            <description>Number of patients who declared a worsening of pain at rest postoperatively</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at Rest</title>
          <description>Subjective evaluation of patients about ther pain at rest, postoperatively versus preoperatively. Patients had to choose among 4 variables : &quot;disappeared&quot;, &quot;less&quot;, &quot;same, &quot;greater&quot;.</description>
          <population>Overall cohort</population>
          <units>Number of Implants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="64"/>
                <count group_id="O3" value="64"/>
                <count group_id="O4" value="64"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="70"/>
                <count group_id="O4" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Survival of the Implant.</title>
        <description>The survival of the implant is evaluated according to the number of implant revisions or of reoperations, whatever the reason.</description>
        <time_frame>mean follow-up of 6.9 years (range, 5.2 - 9.5)</time_frame>
        <population>Overall cohort</population>
        <group_list>
          <group group_id="O1">
            <title>Survival</title>
            <description>Percentage of feet with implant still in place</description>
          </group>
          <group group_id="O2">
            <title>Revisions</title>
            <description>Percentage of feet reoperated for implant ablation</description>
          </group>
        </group_list>
        <measure>
          <title>Survival of the Implant.</title>
          <description>The survival of the implant is evaluated according to the number of implant revisions or of reoperations, whatever the reason.</description>
          <population>Overall cohort</population>
          <units>percentage of implants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected throughout the longest study follow-up, i.e. 144 months.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Overall Cohort</title>
          <description>one consecutive series of patients were included</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>superficial skin infection around the wound</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>inclusion of patients from only 1 site, operated by a single surgeon
lack of control group for comparison with another treatment option
inability to compare preoperative and postoperative AOFAS scores</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Stefano Fieschi</name_or_title>
      <organization>Casa di Cura VIlla Berica</organization>
      <email>stefanofieschi@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

